Zai Lab (ZLAB) Stock
Zai Lab (ZLAB) closed at $23.47 on Nov 16, 2026; its Tenet Score is 38 of 100 against 313 Healthcare peers.
38 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $23.47
- Nov 16, 2026
- 52-week range
- 15.96 – 29.02
- low → high · as of close, Nov 13, 2026
- Tenet Score
- 38/100
- Weak · 313 Healthcare peers
Industry: Drugs
Zai Lab Limited scores 38/100. Weak. Quality is the soft spot versus 313 Healthcare peers. Insufficient inputs: Tenet 38 is built from 3 of 4 pillars, from 50% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=313Factor grades
Value omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Quality Compounder
- ~ Drawdown Context
- ✓ Reversal Evidence
- ✓ Not-a-Value-Trap Gate
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule pol…
Common questions
What sector and industry is Zai Lab in?
Zai Lab is in the Healthcare sector and the Drugs industry.
What is Zai Lab's Tenet Score?
Zai Lab's Tenet Score is 38 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.




